VJOncology is committed to improving our service to you

ESMO Breast 2020 | ShortHER study: validating the AJCC prognostic stage in HER2+ breast cancer

VJOncology is committed to improving our service to you

Maria Vittoria Dieci

Maria Vittoria Dieci, MD, of the University of Padua, Padova, Italy, describes the results of the ShortHER study (NCT00629278) which aimed to validate the introduction of prognostic staging in the American Joint Committee on Cancer (AJCC) guidelines. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

Share this video  
Similar topics

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter